Patrick Richards
Executive Director, Investor Relations and Business Development
Replay available
USANA Health Sciences (NYSE:USNA) Q4 2020 earnings call, held 2021-02-10. Watch the replay and read the transcript on 6ix.

On 6ix: 6ix.com/event/usana-health-sciences-inc-usna-q4-2020-earnings-call
Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.
0:00 Please stand by. We're about to begin. Good day and welcome to the USANA Health Sciences fourth quarter conference call. Today's conference is being recorded. At this time, I would like to turn the conference over to Mr. Patrick Richards, Executive Director of Investor Relations and Business Development. Please go ahead, sir.
0:20 Thank you and good morning. We appreciate you joining us to review our fourth quarter and full year results. Today's conference call is being broadcast live via webcast and can be accessed directly from our website at ir.usana.com. Shortly following the call, a replay will be available on our website. As a reminder, during the course of this conference call, management will make forward-looking statements regarding future events or the future financial performance of our company. Those statements involve risks and uncertainties that could cause actual results to differ. The results are projected in such forward-looking statements. Examples of these statements include those regarding our strategies and outlook for fiscal year 2021, as well as uncertainty related to the magnitude, scope, and duration of the impact of the COVID-19 pandemic for our business, operations, and financial business.
1:14 We caution you that these statements should be considered in conjunction with disclosures, including specific risk factors and financial data contained in our most recent filings I'm joined this morning by our CEO and Chairman of the Board, Kevin Guest, our President, Jim Brown, our Chief Financial Officer, Doug Hekking, as well as other executives. Yesterday after the market closed, we announced our fourth quarter results and posted our management commentary, results, and output document on the company's website. We'll now hear brief remarks from Kevin before opening the call for questions. Thank you, Pat, and good morning, everyone.
1:51 We appreciate you joining us to review our fourth quarter results and former year results as well as our initial outlook for 2021. Overall, we are very pleased with how we performed against the many new and unique challenges of 2020. Our strong performance in the face of an unprecedented pandemic reflects the continued demand for our high-quality nutritional products and successful execution of our strategic initiatives. In 2020, we found that we were well positioned, well prepared, and nimble enough to adapt to and succeed in this unprecedented operating environment. Because of this, we ended the year with more customers, higher net sales, and record earnings per share. As you can see from our initial outlook, we are expecting 2021 to be another record year for USADA.
2:44 2020 was truly a transformative year for our business, as we accelerated many aspects of our customer experience strategy. We've been actively investing in the USANA customer experience for several years now with an emphasis on our digital strategy. In 2020, we capitalized on the groundwork we had already laid and accelerated many other projects to successfully operate during the pandemic. We improved our websites, digital shopping experience, associate trainings, Customer Communications, and our overall technology infrastructure. Additionally, we introduced several new digital tools that allowed our sales force to continue sharing and selling USANA products in a predominantly virtual environment. These enhancements to our business, as well as many other technical and operational improvements, have meaningfully improved the experience that our sales force and customers experience when doing business with USANA.
3:47 Although we recognize that the pandemic is not over, our outlook for fiscal 21 reflects an expectation that we will see progress through 2021 towards a more normalized operating environment. While we've learned a great deal hosting several virtual events this past year, we look forward to the future opportunities of engaging again with our sales force and customers in an in-person setting when it makes sense to do so. Our business is built around fantastic nutritional products, relationships, and personal interactions. We plan to leverage the benefits of both virtual and in-person events moving forward. During the first half of the year, we expect to hold virtual only events for our sales force and maintain our work-from-home plan for employees.
4:38 During the year, we will continue to execute our digital strategy, drive growth in existing markets with our emphasis on China, launch our new active nutrition product line and other products and actively seek out business development opportunities. As we execute this strategy, we are projecting another amazing year for the company. In closing, I am very confident in our strategic direction, the competency and agility of our team, and the strength of USANA's underlying business. With that, I'll now ask the operator to please open the lines for questions. Thank you. The question and answer session will be conducted electronically. And if you would like to ask a question, please press star followed by the digit 1.
5:27 If you are using a speakerphone, please make sure your mute function is turned off to allow your signal to reach our equipment. Once again, star 1. And we'll take our first question from David Bain with Roth Capital.
5:40 Great. Thank you. First, congratulations on a fantastic 4Q execution. I guess my first question would be if you could potentially capsulate the potential route to new market that you suggest in your press release that you're laying the groundwork for. Obviously, that can take many forms such as China did or be strictly organic. Is there any way we can think about the potential immediate impact to a new market in relation to your strategy?
6:12 The strategy for the last several years has been that we wanted to focus our resources on our existing markets and focus on growth where we were currently doing business. We feel like we've got an upper hand in that area and feel very confident that it's time for us to move into exploring other opportunities around the globe. If you look at some of our peer groups there in We do see international expansion as an important piece, but again, like you mentioned, it takes quite a while for it to have an impact.
6:59 Jim, do you want to add? Yeah, I mean, when we look at the markets that we've selected as we go forward, and, of course, at this point in time, when we look at it about 18 to 24 months out, we wouldn't announce that to the field, but we do have a plan and a strategy as we go. There's just a lot of work that has to be done from setting up a market, and that's everything from logistics to where and how we're going to produce our products to hiring the right staff. All of that goes down a path. That's why we're looking at that 18 to 24-month runway before we actually launch the market. You're looking at an impact probably the end of 22 when we look at starting up the market. You'd see a financial impact into 23, so it's a ways out. Again, we feel, and we always have gone down that path of every couple of years of opening a market, that we need to have the right runway to make sure it's a smooth opening. and David, I would add on, I think a little bit of your question is the method and manner we enter China. That's definitely something that we've considered in evaluating whether a partner makes sense as we kind of look at the opportunities.
8:02 And to June's point, a lot of the legwork's been done historically, and we have these markets kind of set on the shelf and kind of timing for when it makes sense. I think the method and the manner, I think we have an idea, but we're still in the process of kind of getting to that point.
8:17 Okay, fantastic. And I guess my follow-up would be, If maybe you could give us a sense as to what benefits, either from a cost structure standpoint or revenue generation through technology or otherwise, just from best practices or really what you've learned that could become permanent out of COVID.
8:39 One of the things that we definitely have learned is that we are very capable on an international level at a very Thank you for having me. One of our big takeaways is that we're going to proceed in the future utilizing a hybrid approach where we're going to leverage technology in a more meaningful way and encapsulate some of the in-person opportunities.
9:34 But just sheerly from a management perspective, I've become very much more accessible to our global community and customer base by leveraging technology. That's a huge learn for us because a significant piece of our spend is done on live events and travel. And it has changed our basic business model somewhat because we have been so used to being on planes, traveling all over the world to get in front of our people. And so that's been a big learn. and it will dramatically change how we do business here.
10:20 I don't know if you guys... Yeah, I mean, the other thing, perhaps from the management team and how we're doing our business, when we look at the sales field, you know, we talk about digital transformation and our digital footprint. We're seeing a huge adoption when it comes to running your business digitally. So as well as the company figuring out how to do it, our field across all of our markets has figured out that way to run their business across Zoom, WeChat, whatever form it is. and to continue down a path of growth. And we were pleasantly surprised in 2020, and I think that's one of the biggest reasons that we had such a great year is that adoption to the digital platforms. David, just a little bit more perspective there. In some of our markets and some pockets within existing markets, we've seen a hesitation or resistance to adopting some of the technology we rolled out.
11:09 and this environment has almost forced them to use it and I think we've heard a pretty good response from that and so that's been kind of a pleasant surprise for us too to go back and get more and more folks using the tools.
11:19 Yeah, for us, you know, I like thinking about it that although COVID has had a negative effect in many people's lives, it's really been an accelerator for USANA and helping us accelerate strategies when we already have a place versus a disruptor and I'm Very grateful that we were able to accelerate things that were already in place when we had to immediately pivot to the new operating environment. And so I see it in a lot of ways from our strategy side, an accelerator versus a disruptor.
11:57 Awesome. And I'm sorry, since it's my first call as an analyst on your stock, If I could ask just one thing as a follow-up to that, deepening digital revenue generation, the whole thing that you've spoken to, are you seeing an overall younger demographic in the network?
12:19 I think, well, this is an anecdotal kind of a response to your question, and Doug has the numbers better than I do, but based upon... What I'm seeing just from a participation, even from a digital perspective, I do see a younger population. Even on my social media accounts and see those who are actively engaging with me as the CEO of a company, I do see a younger group and a younger population continually coming into the business, which I see as very positive. And so, again, this is just my observations. at a very high level, but I would say yes, we do see a younger demographic coming into the business.
13:08 Yeah, I would say as well, from a relevancy aspect, we're set up now to actually meet the demands of that younger crowd, where before, when it was mostly done in person, it really didn't have that effect. Right now, when we're doing everything digitally, that's the platform that the So like Kevin says, we're seeing it. I think in the future we'll see more of it bringing that demographic into the business. And maybe a few other comments there. I think in our higher growth markets, we have a younger demographic, and that's been really clear. I think in some of our other markets, what we've seen is we've seen, you know, to Kevin's point, we've seen some more of this younger group come in, but we've also seen more of our legacy customers start using the technology more.
13:54 So I think all those things are positive. Yeah, I agree with that.
13:58 Fantastic. Congratulations again. Thank you. Thank you. And next we'll move to Sebastian Barbaro with Jefferies.
14:14 Hi. Thanks for taking my question and congrats on recording. A few questions for me, please. I'm wondering first if you could talk about some of the trends you're seeing over on the consumer health market. including changes in customer behavior over the past 12 months and how does this compare across your different markets. And also, if you can talk about retention rates for your associates and customers and how these have trended versus pre-COVID levels.
14:43 As far as kind of the recent trends, Sebastian, I think what we've seen, we talked about it early in 2020. We saw a spike initially as kind of the rest of the world started dealing with the The COVID pandemic, and we saw a spike in some of our immunity products that were designed to go back and support immune functions. And we've definitely seen that spike kind of drift down, but it's still clipping at a higher run rate of growth than the rest of our products. And so without a doubt, we've seen that. Across all our markets, we're seeing a more keen awareness of health and wellness, and it allows us to go back and have more robust conversations and have dialogue with these with these customers and consumers that we have out there. And as it pertains to your second question, we produce that active customer account number for a very specific reason.
15:33 When someone comes in and buys and they don't buy again, typically we don't get something that says, hey, we're gone doing this other stuff. And so that active customer account captures who purchased in the most recent 90-day period. And so we think that's kind of the best transparency metric we use internally as well.
15:52 Got it. And you got it for China to grow between 6% to 12% in 2021, which on an organic basis is likely between flat to up 6%. One thing we can talk about any changes in the market in recent months, including meeting protocols in the competitive landscape, will get you confident that an inflection is in effect over the next four months. and also any call you can give us on early 21 trends and what does your guide imply in terms of growth cadence for the year?
16:29 Yeah, and sorry, Sebastian, it's coming across a little bit muted on your voice. Was this specific to China as you asked the question?
16:40 Yeah, yeah, so just trying to understand any changes in the market in recent months, particularly as it relates to meeting protocols. and also if you can give us some color in early 2021 trends and what this year's guide implies in terms of growth cadence for the year.
17:00 And I'm sure as you read many of the same information that we're getting, China's kind of a nuanced marketplace where you have different restrictions and different guidance really provincially and even at the municipality level. And so I think the questions we're getting leading up to the year is How China had this under control and they weren't having any issues. And you've obviously seen recently in the news they've had these pockets of kind of outbreaks happen. And the China government's really fairly quick to respond. We've always stayed attached to kind of the direction we're getting from our government relations folks and the conversations they're having with the government there. And so we're kind of toeing that line. But we do see, you know, it really is kind of a nuanced thing and it's not real specific to China as a whole.
17:48 But, you know, that factors in kind of the best, you know, estimates we have. The other thing in the market, you know, I think as a whole, what we're getting from our folks at Boots on the Ground is we're seeing overall growth in the market, not really like you saw it in that mid-single digits to mid-single digits plus. You know, we expect to outpace that a little bit. But, you know, that's kind of how we see it right now. The competitive landscape is... Really, you know, not too altered from what we've seen historically. There always are new entrants and stuff. Right now, I think we just haven't seen kind of the same noise in that area. And it really is from established players really kind of getting a foothold and executing their strategies.
18:34 Okay. And in terms of active nutrition, this new line launching in Q2, you mentioned you'll have a focus in weight management and digestive health. Will this be some sort of shake or will it be a full comprehensive weight loss program backed by some digital tech embedded in it?
18:55 Yeah, the active nutrition is more of a full program. Right now what I would consider our line to be is a foods line with our Nutramil and the products there. We're looking at shakes, bringing back bars, as we've mentioned in past calls, We have a USANA North facility, which literally is a stone's throw away from where we're sitting at our corporate headquarters, and we're going to be making our own powdered beverages and bars in that facility. We've actually started already because we're looking at launching active nutrition, and we talked about that. Really, the impact for a handful of markets will be in the second quarter, and then we're going to have additional phases of launch throughout 2021. So we'll see the full impact of active nutrition really into 2022, but we'll see those trends happening in the third and fourth quarter this year.
19:40 But it's much more than just a foods launch. It's programs, there's influencers, there's all kinds of different ways to get more of a community around the experience instead of just more foods. And so this is a little bit of a novel approach from how we've approached different product introductions in the past.
19:59 And for us, there's a real focus on lifestyle versus a product or two that are being launched out there. If we can truly affect someone's lifestyle in a positive way to improve their health, we're really wanting to take a more holistic approach to the lifestyle as we move forward. And so we're excited. as a health company to be able to round out our offering in those categories.
20:32 Got it. Okay. And last one from me. Switching to your capital allocation priorities. There's a lack of buybacks in Q4, you know, results of building cash for strategic partnerships. And if that's the case, can you walk us a little bit, can you give us a little more details around your M&A criteria? You know, you're looking for companies Thank you for your question.
21:20 The focal point has really been on kind of an organic business. We also are actively looking for things that don't necessarily fit directly in the direct selling business that we can go back and acquire a core competency that we can leverage in our other channels as well. You know, you used the built brand as a great example to go back and accelerate our understanding, our know-how to go back and execute on what we have. And so those are good examples. I think geographic expansion, we look at vertical integration, technology, Anything to go back and kind of play in the health and wellness space. And, you know, I think in many of those things, even if it's not directly correlated to the direct sales channel at this point, we believe those opportunities are there as leverage going forward. And then regarding leverage and stuff, yeah, we see opportunities and stuff without a doubt. We're not afraid to go back and put a couple times even down the books of debt.
22:10 You know, we're just looking for that opportunity. And believe me, the deal flow that we're evaluating on a regular basis now is, is far beyond what we've done historically, and we're looking for those opportunities and really evaluating those on a pretty dynamic basis.
22:26 Got it. Thank you. And next, we'll move to Doug Lane with Lane Research.
22:34 Yeah, hi. Good morning, everybody. I just want to focus, if we could. I just want to focus, if we could, on the customer counts, and to a lesser extent, even the active associate counts, where it's really been a tale of two stories this year, where outside of China, the growth has been remarkable, but inside China, it just doesn't seem to be getting any better. So if we could start with the good, the 30% increase in active preferred customers year over year outside of China. I mean, how... How sustainable is that and what kind of number should we be thinking about for 2021 as far as that's concerned?
23:14 Yeah, I would say over the last couple of years, the strategy that Kevin's encouraged the group to go back and adopt is really focusing on the consumer. And you see in all our markets across the globe that focus first and foremost on the customer. At the end of the day, we grow the company by having more individuals and families consume our products. and I think if we do that incredibly well and we've been executing on it, I think that makes it easier and easier for associates going forward as well from a business opportunity perspective. So that focus hasn't changed and we'll keep leaning into that going forward. China's had a couple unique challenges back to back in a couple years. and so that's, you know, I think we're coming out of that. I think the China team over there really worked hard to go back and build a base so we can really leverage going forward and the feedback we get is they're encouraged and excited about the opportunities we have going forward and really, you know, see some momentum moving forward in the business.
24:10 Yeah, on China, I think the one concern that I would have, again, it was a great quarter, but the one sort of number that stuck out on the concern side was that the preferred customer number was Decelerated so much sequentially from 193,000 to 164,000. So what happened in the quarter to impact the customer number in China?
24:32 Yeah, you know, it had to do with that trial program that we ran beginning into Q2 and Q3. And it really encouraged our associates to go back and just share the opportunity. And we created a very linear compensation for a short period of time. and so it really encouraged them to go back and reach out and attract and as that trial program ended you saw some of those numbers drift down and even with the decay and some of those lift in the customer numbers in Q3 overall I think our Q4 numbers were catalyzed by the momentum created from that program as a company as a whole and we also benefited moderately from currency but that was the primary catalyst in the change in accounts there.
25:15 Are you seeing any lift in China? I mean, especially on the active associates. We saw to a lesser extent a deceleration there as well. But, you know, the associate count in China continues to sort of drift lower here. So I'm wondering, are you looking for an improvement in 2021 or just sort of stabilization in China? I mean, again, I'd go in China because it's almost half your business.
25:40 Yeah, I think we're looking for progress there. You can go back and see that reflected in kind of the outlook numbers that we have. We're not going to go back and grow unless the customers are moving in the right direction. I think the confidence is there and kind of the momentum is there and the plans are there and the strategy. This is an investment here for China, and they're taking full advantage of that, and we see progress in executing those investments.
26:03 Okay. Thanks, Doug. Next, we'll move to Ivan Feinsip with Tigris Financial Partners.
26:17 Thanks for taking my call, and congratulations on another great quarter. Thanks. What were the strongest product categories and the strongest products in the most recent quarter, and what kind of product trends are you seeing? What product demand trends and interest from customers and associates are you seeing?
26:37 Yeah, like Doug mentioned a little bit earlier, the immune health continues to be the product line that's outpacing anything else. And then when we look at it, you know, we did a lot of programs throughout 2021 from a promotional activity as well, from incentives as well as product launches. I mean, we launched more products in 2020 than we ever have. And, you know, that was part of our overall strategy to – and many more.
27:33 How are you helping your associates to educate and market immune health and that it should continue long after hopefully the pandemic is in the rearview mirror?
27:44 I think that's just part of who you saw me as. I mean, part of what we do is training to make sure that our associates can tell the story of our products and why the high quality is needed throughout the world. And we continue to do that in the markets. And we talked a little bit about the Thank you for joining us. I would say the other thing is years ago we acquired a production company that makes incredible content and it really is a dynamic way to go back and share the message in education.
28:48 One of the things that our China market has planned this year is to go back and replicate a lot of that capability within market. It'll go back and build brand awareness, feed content velocity, many really positive things there that they're working on and so more and more we continue to go back and kind of leverage that know-how and expertise and find creative ways to to share that information in a digital way.
29:13 And how do you envision what kind of events are you going to have for the Active Nutrition launch?
29:20 Yeah, I mean, right now those events, and we're really launching a handful of markets to start with, U.S., Canada, Mexico, Australia, and New Zealand will be following shortly. And those will be virtual events that we train our associates using WebEx or Zoom mostly for those markets. and, you know, it's going to be training on the products themselves, but also the programs that go along with it. We're also doing user trials at the moment, so that information will come out during that, and it's all been positive thus far. We're really excited about active nutrition, and for us, another area that we talk about from an excitement standpoint is bringing that technology and producing those products ourselves at the company. It's been something over the last, well, I've been at Desana 15 years. It's been my biggest headache. and many more.
30:07 Thank you.
30:37 Business Builder Associates out there who are our health advocates. And we're actually currently having them involved with the product, working with our science team, our R&D team, getting that expertise that they, from a product knowledge perspective, as well as helping us put a program together and assist us directly with boots on the ground It's almost like a working focus group that is helping us build to the launch. And so we already have embedded, so to speak, a group of advocates who've had great experiences with the product as ambassadors throughout these markets, which will give us a huge boost as we launch the products.
31:25 And what do you feel the size of the active market, active nutrition market is relative to your current market? I mean, there are a lot of and other companies that purely do sports-related, performance-related stuff. It is pretty big. And what do you think is going to be your unique attributes and your competitive advantage when you go into this?
31:50 So just for clarity, Ivan, I think that whole kind of fitness and exercise stuff will be a little bit down the road. Initially we're going to be focusing on kind of weight management, healthy snacks. We think the market's a really large market. and it's something we can go back and really leverage our existing customer base to go back and help tell the story through some of the technology we've talked about. So we think it's a big opportunity. I think just managing expectations here a little bit, first and foremost, Jim and Walter Noot, our chief operating officer, have really been working hard to go back and get that production operation up and going in a very thoughtful, meaningful way. And then after that, we're going to launch in select markets. in Q2 and just systematically roll that out and start broadening out the product base. And it really is a more holistic offering.
32:36 I think so many things we see out there are very just product-focused, and we plan to definitely have something that's broader than that, which would roll in things for nutrition and exercise and those types of things going forward as well.
32:50 And then on, I guess this is the first call since you announced your investment in Built Brands. You go into a little detail about what attracted you to, what opportunities you see, how you're going to work with them, what's going to be the benefit to USANA, and as consumers of your product, what can they expect from you?
33:13 Yeah, with BuildBrand, the deal itself was an investment in the company, a minority investment, but what we really were interested in was some of the aspects that we gained from that company. They're right down the road from us, maybe 30 minutes, Thank you for joining us. Formulation and R&D team to help us create a USANA bar with some of the learnings that they have and some of the technology that they have.
34:00 And that will probably turn into many bars in the future. And again, that's going to speed up the process for us as USANA to launch a product because we'll be able to use their expertise. And really, it wasn't as much about the investment, which we have our high hopes that we'll get a great return from that investment, but it was about the operational excellence and The ability to get a new bar from an R&D standpoint quicker than our normal process.
34:28 And just, Ivan, from my perspective as a CEO, I had the great opportunity to go down to Bilt Bar and sit with their CEO for a couple hours. And we were able to strategically brainstorm. How could we have some synergies together? They're in a completely different market that we're in.
34:48 They have a completely different approach.
34:51 to how they deliver and manufacture and sell products. And so for me, the synergies that come from someone who's actually serving somewhat the health versus an active nutrition market already in a different way is very important from a learning perspective on top of investment opportunity which I think is a very great use of our capital and also gaining the new core competency but also the synergies that come from us being a partner with someone who has somewhat of a similar business but yet does it in a completely different way.
35:30 It's exciting, and I am looking forward to the active nutrition launch and more about the USANA bar. I mean, they tend to lean keto, paleo, which I think is a big market. More than a fad, but I think it is an important nutrition focus. What are your thoughts on that?
35:53 We'll be looking for borrow pennies to go back, and we have obviously some protein, but also some nutritional benefit as well with different focal areas. So that's something that we've been developing and looking down the path. I wouldn't say that we have anything specifically. We definitely have some things that are catered towards health benefits.
36:11 Just to that point also, we're always looking for different ways to deliver nutrition. With some of these bars, we've had prototypes where we've had them fortified with various vitamins and minerals within a very tasty chocolate bar. It's a great different delivery system that we're exploring also as we look at Thank you for joining us.
36:57 as an offering. Now with the new foods plan and having that supply chain managed by ourselves, we could have a lot more entries into the bar area as well as the powdered beverage area because we're not held under the same contractual obligations that we are with third parties with really large runs and everything else that makes it more complicated to have a lot of variations. So that's something that we're going to be able to support the active nutrition line with.
37:28 I appreciate the insight and the update and congratulations again on the results and wish you much more ongoing success in 2021.
37:37 Thank you. Thanks, Ivan. And that will conclude the question and answer session at this time. I would like to turn the call back over to Mr. Patrick Richards for an additional or closing remark.
37:52 Thank you for your questions and for your participation on today's conference call. If you have any remaining questions, please feel free and 954-7358. And that will conclude today's call. We thank you for your participation.
Follow USANA Health Sciences, Inc. into a list and get an email when it puts out news.
Executive Director, Investor Relations and Business Development
Chief Executive Officer & Chairman of the Board
Analyst, Roth Capital
Analyst, Jefferies
Analyst, Lane Research
Analyst, Tigris Financial Partners